[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fYWwJhsGcozJbC_ejA0l_cmpEvcLaEvTQN_WRPkles78":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":34,"phaseBuckets":65,"rows":72},"October 6 University",[4],129,false,22,5,7462,10,99,[14,17,20,23,25,27,30,32],{"name":15,"count":16},"Stroke",8,{"name":18,"count":19},"Low Back Pain",4,{"name":21,"count":22},"Carpal Tunnel Syndrome",3,{"name":24,"count":22},"Rehabilitation",{"name":26,"count":22},"Cervical Radiculopathy",{"name":28,"count":29},"Rheumatoid Arthritis",2,{"name":31,"count":29},"Diabetic Neuropathies",{"name":33,"count":29},"Fibromyalgia",[35,40,45,50,55,60],{"nctId":36,"briefTitle":37,"date":38,"intervention":39},"NCT06491992","Chitosan Phonophresis on Cervical IN Smartphone Addicted Users","2024-09-30","Chitosan Phonophresis",{"nctId":41,"briefTitle":42,"date":43,"intervention":44},"NCT06708481","Resin Infiltration Vs Self-Assembling Peptide (P11-4) in Treating White Spot Lesions","2025-02","P11-4, a self-assembling peptide",{"nctId":46,"briefTitle":47,"date":48,"intervention":49},"NCT05264025","Fexofenadine in Patients With Active Rheumatoid Arthritis","2025-12","Fexofenadine",{"nctId":51,"briefTitle":52,"date":53,"intervention":54},"NCT06142656","Efficacy of Vildagliptin Versus Metformin in Poly Cystic Ovary Syndrome","2025-12-01","Metformin Hydrochloride",{"nctId":56,"briefTitle":57,"date":58,"intervention":59},"NCT05821075","Efficacy of Prednisolone Versus Cerebrolysin in the Treatment of Bell's Palsy","2026-01","Prednisolone",{"nctId":61,"briefTitle":62,"date":63,"intervention":64},"NCT07537868","Effect of Montelukast on Inflammatory Markers and Cardiac Injury in Patients With Acute Myocardial Infarction","2027-05","Montelukast 10 Mg Oral",[66,67,68,69,70,71],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[73,99,117,137,160,178,199,222,240,258,280,308,326,357,375,393,411,429,458,476,504,522,548,566,593,611,649,677,695,713,739,757,781,799,823,841,866,893,911,929,954,978,1003,1026,1053,1071,1098,1127,1145,1163,1181,1206,1224,1250],{"intervention":54,"totalTrials":74,"cells":75},1,{"EARLY_PHASE1":76,"PHASE1":79,"PHASE2":81,"PHASE3":83,"PHASE4":95,"NA":97},{"trials":77,"activeCount":78},[],0,{"trials":80,"activeCount":78},[],{"trials":82,"activeCount":78},[],{"trials":84,"activeCount":74,"soonestReadout":53},[85],{"nctId":51,"briefTitle":52,"status":86,"phases":87,"primaryCompletion":53,"completion":88,"start":89,"enrollment":90,"conditions":91,"interventions":93},"RECRUITING",[68,69],"2026-02-01","2023-11-25",60,[92],"Poly Cystic Ovary Syndrome",[54,94],"Vildagliptin 50 MG",{"trials":96,"activeCount":78},[],{"trials":98,"activeCount":78},[],{"intervention":94,"totalTrials":74,"cells":100},{"EARLY_PHASE1":101,"PHASE1":103,"PHASE2":105,"PHASE3":107,"PHASE4":113,"NA":115},{"trials":102,"activeCount":78},[],{"trials":104,"activeCount":78},[],{"trials":106,"activeCount":78},[],{"trials":108,"activeCount":74,"soonestReadout":53},[109],{"nctId":51,"briefTitle":52,"status":86,"phases":110,"primaryCompletion":53,"completion":88,"start":89,"enrollment":90,"conditions":111,"interventions":112},[68,69],[92],[54,94],{"trials":114,"activeCount":78},[],{"trials":116,"activeCount":78},[],{"intervention":49,"totalTrials":74,"cells":118},{"EARLY_PHASE1":119,"PHASE1":121,"PHASE2":123,"PHASE3":131,"PHASE4":133,"NA":135},{"trials":120,"activeCount":78},[],{"trials":122,"activeCount":78},[],{"trials":124,"activeCount":74,"soonestReadout":48},[125],{"nctId":46,"briefTitle":47,"status":86,"phases":126,"primaryCompletion":48,"completion":58,"start":127,"enrollment":128,"conditions":129,"interventions":130},[67,68],"2022-06-01",80,[28],[49],{"trials":132,"activeCount":78},[],{"trials":134,"activeCount":78},[],{"trials":136,"activeCount":78},[],{"intervention":59,"totalTrials":74,"cells":138},{"EARLY_PHASE1":139,"PHASE1":141,"PHASE2":143,"PHASE3":154,"PHASE4":156,"NA":158},{"trials":140,"activeCount":78},[],{"trials":142,"activeCount":78},[],{"trials":144,"activeCount":74,"soonestReadout":58},[145],{"nctId":56,"briefTitle":57,"status":86,"phases":146,"primaryCompletion":58,"completion":147,"start":148,"enrollment":149,"conditions":150,"interventions":152},[67,68],"2026-02","2023-08-24",90,[151],"Bell Palsy",[59,153],"Cerebrolysin",{"trials":155,"activeCount":78},[],{"trials":157,"activeCount":78},[],{"trials":159,"activeCount":78},[],{"intervention":153,"totalTrials":74,"cells":161},{"EARLY_PHASE1":162,"PHASE1":164,"PHASE2":166,"PHASE3":172,"PHASE4":174,"NA":176},{"trials":163,"activeCount":78},[],{"trials":165,"activeCount":78},[],{"trials":167,"activeCount":74,"soonestReadout":58},[168],{"nctId":56,"briefTitle":57,"status":86,"phases":169,"primaryCompletion":58,"completion":147,"start":148,"enrollment":149,"conditions":170,"interventions":171},[67,68],[151],[59,153],{"trials":173,"activeCount":78},[],{"trials":175,"activeCount":78},[],{"trials":177,"activeCount":78},[],{"intervention":64,"totalTrials":74,"cells":179},{"EARLY_PHASE1":180,"PHASE1":182,"PHASE2":184,"PHASE3":193,"PHASE4":195,"NA":197},{"trials":181,"activeCount":78},[],{"trials":183,"activeCount":78},[],{"trials":185,"activeCount":74,"soonestReadout":63},[186],{"nctId":61,"briefTitle":62,"status":86,"phases":187,"primaryCompletion":63,"completion":188,"start":189,"enrollment":128,"conditions":190,"interventions":192},[68],"2027-10","2026-04-20",[191],"Acute Myocardial Infarction (AMI)",[64],{"trials":194,"activeCount":78},[],{"trials":196,"activeCount":78},[],{"trials":198,"activeCount":78},[],{"intervention":44,"totalTrials":74,"cells":200},{"EARLY_PHASE1":201,"PHASE1":212,"PHASE2":214,"PHASE3":216,"PHASE4":218,"NA":220},{"trials":202,"activeCount":74,"soonestReadout":43},[203],{"nctId":41,"briefTitle":42,"status":86,"phases":204,"primaryCompletion":43,"completion":43,"start":205,"enrollment":206,"conditions":207,"interventions":209},[66],"2024-08-30",150,[208],"White Spot Lesion",[44,210,211],"P11-4, a self-assembling peptide with flouride","resin infilteration",{"trials":213,"activeCount":78},[],{"trials":215,"activeCount":78},[],{"trials":217,"activeCount":78},[],{"trials":219,"activeCount":78},[],{"trials":221,"activeCount":78},[],{"intervention":210,"totalTrials":74,"cells":223},{"EARLY_PHASE1":224,"PHASE1":230,"PHASE2":232,"PHASE3":234,"PHASE4":236,"NA":238},{"trials":225,"activeCount":74,"soonestReadout":43},[226],{"nctId":41,"briefTitle":42,"status":86,"phases":227,"primaryCompletion":43,"completion":43,"start":205,"enrollment":206,"conditions":228,"interventions":229},[66],[208],[44,210,211],{"trials":231,"activeCount":78},[],{"trials":233,"activeCount":78},[],{"trials":235,"activeCount":78},[],{"trials":237,"activeCount":78},[],{"trials":239,"activeCount":78},[],{"intervention":211,"totalTrials":74,"cells":241},{"EARLY_PHASE1":242,"PHASE1":248,"PHASE2":250,"PHASE3":252,"PHASE4":254,"NA":256},{"trials":243,"activeCount":74,"soonestReadout":43},[244],{"nctId":41,"briefTitle":42,"status":86,"phases":245,"primaryCompletion":43,"completion":43,"start":205,"enrollment":206,"conditions":246,"interventions":247},[66],[208],[44,210,211],{"trials":249,"activeCount":78},[],{"trials":251,"activeCount":78},[],{"trials":253,"activeCount":78},[],{"trials":255,"activeCount":78},[],{"trials":257,"activeCount":78},[],{"intervention":39,"totalTrials":74,"cells":259},{"EARLY_PHASE1":260,"PHASE1":262,"PHASE2":264,"PHASE3":266,"PHASE4":268,"NA":270},{"trials":261,"activeCount":78},[],{"trials":263,"activeCount":78},[],{"trials":265,"activeCount":78},[],{"trials":267,"activeCount":78},[],{"trials":269,"activeCount":78},[],{"trials":271,"activeCount":74,"soonestReadout":38},[272],{"nctId":36,"briefTitle":37,"status":86,"phases":273,"primaryCompletion":38,"completion":274,"start":275,"enrollment":276,"conditions":277,"interventions":279},[71],"2024-10-15","2024-07-01",30,[278],"Cervical Pain",[39],{"intervention":281,"totalTrials":74,"cells":282},"Aloe vera gel",{"EARLY_PHASE1":283,"PHASE1":285,"PHASE2":287,"PHASE3":289,"PHASE4":291,"NA":306},{"trials":284,"activeCount":78},[],{"trials":286,"activeCount":78},[],{"trials":288,"activeCount":78},[],{"trials":290,"activeCount":78},[],{"trials":292,"activeCount":78},[293],{"nctId":294,"briefTitle":295,"status":296,"phases":297,"primaryCompletion":298,"completion":299,"start":300,"enrollment":301,"conditions":302,"interventions":304},"NCT06879366","Evaluation of the Efficacy of Aloe-Vera el Versus Bezydamine Hydrochloride in the Prevention of Radiation Induced Oral Mucositis A Randamized Controlled Clinical Trial","COMPLETED",[70],"2024-12-01","2025-03-01","2023-06-01",40,[303],"Head and Neck Cancer Patients Treated With Radiotherapy",[281,305],"Benzydamine Hydrochloride 0.15% Oral gel",{"trials":307,"activeCount":78},[],{"intervention":305,"totalTrials":74,"cells":309},{"EARLY_PHASE1":310,"PHASE1":312,"PHASE2":314,"PHASE3":316,"PHASE4":318,"NA":324},{"trials":311,"activeCount":78},[],{"trials":313,"activeCount":78},[],{"trials":315,"activeCount":78},[],{"trials":317,"activeCount":78},[],{"trials":319,"activeCount":78},[320],{"nctId":294,"briefTitle":295,"status":296,"phases":321,"primaryCompletion":298,"completion":299,"start":300,"enrollment":301,"conditions":322,"interventions":323},[70],[303],[281,305],{"trials":325,"activeCount":78},[],{"intervention":327,"totalTrials":74,"cells":328},"Remdesivir",{"EARLY_PHASE1":329,"PHASE1":331,"PHASE2":333,"PHASE3":335,"PHASE4":337,"NA":355},{"trials":330,"activeCount":78},[],{"trials":332,"activeCount":78},[],{"trials":334,"activeCount":78},[],{"trials":336,"activeCount":78},[],{"trials":338,"activeCount":78},[339],{"nctId":340,"briefTitle":341,"status":342,"phases":343,"primaryCompletion":344,"completion":345,"start":346,"enrollment":206,"conditions":347,"interventions":350},"NCT04779047","Comparative Therapeutic Efficacy and Safety of Different Antiviral and Anti Inflammatory Drugs in COVID-19 Patients.","UNKNOWN",[70],"2021-03-10","2021-04-05","2020-10-01",[348,349],"Covid19","Pneumonia",[327,351,352,353,354],"Hydroxychloroquine","Tocilizumab","Lopinavir\u002F Ritonavir","Ivermectin",{"trials":356,"activeCount":78},[],{"intervention":351,"totalTrials":74,"cells":358},{"EARLY_PHASE1":359,"PHASE1":361,"PHASE2":363,"PHASE3":365,"PHASE4":367,"NA":373},{"trials":360,"activeCount":78},[],{"trials":362,"activeCount":78},[],{"trials":364,"activeCount":78},[],{"trials":366,"activeCount":78},[],{"trials":368,"activeCount":78},[369],{"nctId":340,"briefTitle":341,"status":342,"phases":370,"primaryCompletion":344,"completion":345,"start":346,"enrollment":206,"conditions":371,"interventions":372},[70],[348,349],[327,351,352,353,354],{"trials":374,"activeCount":78},[],{"intervention":352,"totalTrials":74,"cells":376},{"EARLY_PHASE1":377,"PHASE1":379,"PHASE2":381,"PHASE3":383,"PHASE4":385,"NA":391},{"trials":378,"activeCount":78},[],{"trials":380,"activeCount":78},[],{"trials":382,"activeCount":78},[],{"trials":384,"activeCount":78},[],{"trials":386,"activeCount":78},[387],{"nctId":340,"briefTitle":341,"status":342,"phases":388,"primaryCompletion":344,"completion":345,"start":346,"enrollment":206,"conditions":389,"interventions":390},[70],[348,349],[327,351,352,353,354],{"trials":392,"activeCount":78},[],{"intervention":353,"totalTrials":74,"cells":394},{"EARLY_PHASE1":395,"PHASE1":397,"PHASE2":399,"PHASE3":401,"PHASE4":403,"NA":409},{"trials":396,"activeCount":78},[],{"trials":398,"activeCount":78},[],{"trials":400,"activeCount":78},[],{"trials":402,"activeCount":78},[],{"trials":404,"activeCount":78},[405],{"nctId":340,"briefTitle":341,"status":342,"phases":406,"primaryCompletion":344,"completion":345,"start":346,"enrollment":206,"conditions":407,"interventions":408},[70],[348,349],[327,351,352,353,354],{"trials":410,"activeCount":78},[],{"intervention":354,"totalTrials":74,"cells":412},{"EARLY_PHASE1":413,"PHASE1":415,"PHASE2":417,"PHASE3":419,"PHASE4":421,"NA":427},{"trials":414,"activeCount":78},[],{"trials":416,"activeCount":78},[],{"trials":418,"activeCount":78},[],{"trials":420,"activeCount":78},[],{"trials":422,"activeCount":78},[423],{"nctId":340,"briefTitle":341,"status":342,"phases":424,"primaryCompletion":344,"completion":345,"start":346,"enrollment":206,"conditions":425,"interventions":426},[70],[348,349],[327,351,352,353,354],{"trials":428,"activeCount":78},[],{"intervention":430,"totalTrials":74,"cells":431},"Canagliflozin",{"EARLY_PHASE1":432,"PHASE1":434,"PHASE2":436,"PHASE3":438,"PHASE4":454,"NA":456},{"trials":433,"activeCount":78},[],{"trials":435,"activeCount":78},[],{"trials":437,"activeCount":78},[],{"trials":439,"activeCount":78},[440],{"nctId":441,"briefTitle":442,"status":296,"phases":443,"primaryCompletion":444,"completion":445,"start":446,"enrollment":447,"conditions":448,"interventions":452},"NCT05364190","Canagliflozin in Patients With Acute Decompansted Heart Failure",[69],"2023-12-01","2024-03-01","2022-06-04",142,[449,450,451],"Chronic Heart Failure","Acute Heart Failure","Diabetes Mellitus",[430,453],"Empagliflozin",{"trials":455,"activeCount":78},[],{"trials":457,"activeCount":78},[],{"intervention":453,"totalTrials":74,"cells":459},{"EARLY_PHASE1":460,"PHASE1":462,"PHASE2":464,"PHASE3":466,"PHASE4":472,"NA":474},{"trials":461,"activeCount":78},[],{"trials":463,"activeCount":78},[],{"trials":465,"activeCount":78},[],{"trials":467,"activeCount":78},[468],{"nctId":441,"briefTitle":442,"status":296,"phases":469,"primaryCompletion":444,"completion":445,"start":446,"enrollment":447,"conditions":470,"interventions":471},[69],[449,450,451],[430,453],{"trials":473,"activeCount":78},[],{"trials":475,"activeCount":78},[],{"intervention":477,"totalTrials":74,"cells":478},"Colistin",{"EARLY_PHASE1":479,"PHASE1":481,"PHASE2":483,"PHASE3":485,"PHASE4":500,"NA":502},{"trials":480,"activeCount":78},[],{"trials":482,"activeCount":78},[],{"trials":484,"activeCount":78},[],{"trials":486,"activeCount":78},[487],{"nctId":488,"briefTitle":489,"status":342,"phases":490,"primaryCompletion":491,"completion":492,"start":493,"enrollment":494,"conditions":495,"interventions":498},"NCT05613361","The Effect of Curcumin Against Colistin-induced Nephrotoxicity",[69],"2024-04-30","2024-10-30","2023-01-01",214,[496,497],"Acute Kidney Injury","Drug-Induced Nephropathy",[477,499],"Curcumin",{"trials":501,"activeCount":78},[],{"trials":503,"activeCount":78},[],{"intervention":499,"totalTrials":74,"cells":505},{"EARLY_PHASE1":506,"PHASE1":508,"PHASE2":510,"PHASE3":512,"PHASE4":518,"NA":520},{"trials":507,"activeCount":78},[],{"trials":509,"activeCount":78},[],{"trials":511,"activeCount":78},[],{"trials":513,"activeCount":78},[514],{"nctId":488,"briefTitle":489,"status":342,"phases":515,"primaryCompletion":491,"completion":492,"start":493,"enrollment":494,"conditions":516,"interventions":517},[69],[496,497],[477,499],{"trials":519,"activeCount":78},[],{"trials":521,"activeCount":78},[],{"intervention":523,"totalTrials":74,"cells":524},"Dapagliflozin Farxiga®",{"EARLY_PHASE1":525,"PHASE1":527,"PHASE2":529,"PHASE3":531,"PHASE4":544,"NA":546},{"trials":526,"activeCount":78},[],{"trials":528,"activeCount":78},[],{"trials":530,"activeCount":78},[],{"trials":532,"activeCount":78},[533],{"nctId":534,"briefTitle":535,"status":296,"phases":536,"primaryCompletion":537,"completion":538,"start":539,"enrollment":206,"conditions":540,"interventions":542},"NCT05849766","Effect of Dapagliflozin on Cardiac Structure, Function and Secondary Mitral Regurgitation in Patients with Left Ventricle Dysfunction",[69],"2024-05-01","2024-09-01","2023-04-27",[541],"Dilated Cardiomyopathy",[523,543],"Ramipril Tritace®, Carvedilol Carvid®,and Spironolactone Aldactone®",{"trials":545,"activeCount":78},[],{"trials":547,"activeCount":78},[],{"intervention":543,"totalTrials":74,"cells":549},{"EARLY_PHASE1":550,"PHASE1":552,"PHASE2":554,"PHASE3":556,"PHASE4":562,"NA":564},{"trials":551,"activeCount":78},[],{"trials":553,"activeCount":78},[],{"trials":555,"activeCount":78},[],{"trials":557,"activeCount":78},[558],{"nctId":534,"briefTitle":535,"status":296,"phases":559,"primaryCompletion":537,"completion":538,"start":539,"enrollment":206,"conditions":560,"interventions":561},[69],[541],[523,543],{"trials":563,"activeCount":78},[],{"trials":565,"activeCount":78},[],{"intervention":567,"totalTrials":74,"cells":568},"Probiotic Blend Oral",{"EARLY_PHASE1":569,"PHASE1":571,"PHASE2":573,"PHASE3":575,"PHASE4":589,"NA":591},{"trials":570,"activeCount":78},[],{"trials":572,"activeCount":78},[],{"trials":574,"activeCount":78},[],{"trials":576,"activeCount":78},[577],{"nctId":578,"briefTitle":579,"status":342,"phases":580,"primaryCompletion":581,"completion":582,"start":583,"enrollment":584,"conditions":585,"interventions":587},"NCT06119672","Efficacy of Probiotic Capsules With Topical Clobetasol Propionate in OLP Treatment",[69],"2023-10-30","2023-12-30","2023-05-01",36,[586],"Oral Lichen Planus",[567,588],"Corticosteroids for Local Oral Treatment",{"trials":590,"activeCount":78},[],{"trials":592,"activeCount":78},[],{"intervention":588,"totalTrials":74,"cells":594},{"EARLY_PHASE1":595,"PHASE1":597,"PHASE2":599,"PHASE3":601,"PHASE4":607,"NA":609},{"trials":596,"activeCount":78},[],{"trials":598,"activeCount":78},[],{"trials":600,"activeCount":78},[],{"trials":602,"activeCount":78},[603],{"nctId":578,"briefTitle":579,"status":342,"phases":604,"primaryCompletion":581,"completion":582,"start":583,"enrollment":584,"conditions":605,"interventions":606},[69],[586],[567,588],{"trials":608,"activeCount":78},[],{"trials":610,"activeCount":78},[],{"intervention":612,"totalTrials":29,"cells":613},"Conventional therapy",{"EARLY_PHASE1":614,"PHASE1":616,"PHASE2":618,"PHASE3":643,"PHASE4":645,"NA":647},{"trials":615,"activeCount":78},[],{"trials":617,"activeCount":78},[],{"trials":619,"activeCount":78},[620,631],{"nctId":621,"briefTitle":622,"status":296,"phases":623,"primaryCompletion":624,"completion":625,"start":626,"enrollment":90,"conditions":627,"interventions":629},"NCT06140953","Benefits of Trimetazidine in MASLD Patients",[68],"2024-06-01","2024-11-30","2023-12-10",[628],"Metabolic Associated Fatty Liver Disease",[630,612],"Trimetazidine",{"nctId":632,"briefTitle":633,"status":342,"phases":634,"primaryCompletion":635,"completion":48,"start":636,"enrollment":90,"conditions":637,"interventions":640},"NCT05966025","Potential Benefits of Itopride in the Management of Patients With Metabolic Associated Fatty Liver Disease (MAFLD)",[68],"2024-12","2023-12-28",[638,639],"Fatty Liver Disease","Fatty Liver",[641,642],"Itopride","conventional therapy",{"trials":644,"activeCount":78},[],{"trials":646,"activeCount":78},[],{"trials":648,"activeCount":78},[],{"intervention":650,"totalTrials":74,"cells":651},"Pregabalin 150mg",{"EARLY_PHASE1":652,"PHASE1":654,"PHASE2":656,"PHASE3":671,"PHASE4":673,"NA":675},{"trials":653,"activeCount":78},[],{"trials":655,"activeCount":78},[],{"trials":657,"activeCount":78},[658],{"nctId":659,"briefTitle":660,"status":296,"phases":661,"primaryCompletion":662,"completion":663,"start":664,"enrollment":665,"conditions":666,"interventions":668},"NCT05547659","Multimodal and Unimodal Analgesia in Cholecystectomy",[67,68],"2020-04-01","2020-12-01","2019-01-01",95,[667],"Compare Unimodal and Multimodal Analgesics",[650,669,670],"Acetaminophen 1 G Oral","Celecoxib 400Mg Oral",{"trials":672,"activeCount":78},[],{"trials":674,"activeCount":78},[],{"trials":676,"activeCount":78},[],{"intervention":669,"totalTrials":74,"cells":678},{"EARLY_PHASE1":679,"PHASE1":681,"PHASE2":683,"PHASE3":689,"PHASE4":691,"NA":693},{"trials":680,"activeCount":78},[],{"trials":682,"activeCount":78},[],{"trials":684,"activeCount":78},[685],{"nctId":659,"briefTitle":660,"status":296,"phases":686,"primaryCompletion":662,"completion":663,"start":664,"enrollment":665,"conditions":687,"interventions":688},[67,68],[667],[650,669,670],{"trials":690,"activeCount":78},[],{"trials":692,"activeCount":78},[],{"trials":694,"activeCount":78},[],{"intervention":670,"totalTrials":74,"cells":696},{"EARLY_PHASE1":697,"PHASE1":699,"PHASE2":701,"PHASE3":707,"PHASE4":709,"NA":711},{"trials":698,"activeCount":78},[],{"trials":700,"activeCount":78},[],{"trials":702,"activeCount":78},[703],{"nctId":659,"briefTitle":660,"status":296,"phases":704,"primaryCompletion":662,"completion":663,"start":664,"enrollment":665,"conditions":705,"interventions":706},[67,68],[667],[650,669,670],{"trials":708,"activeCount":78},[],{"trials":710,"activeCount":78},[],{"trials":712,"activeCount":78},[],{"intervention":714,"totalTrials":74,"cells":715},"omega-3",{"EARLY_PHASE1":716,"PHASE1":718,"PHASE2":720,"PHASE3":733,"PHASE4":735,"NA":737},{"trials":717,"activeCount":78},[],{"trials":719,"activeCount":78},[],{"trials":721,"activeCount":78},[722],{"nctId":723,"briefTitle":724,"status":342,"phases":725,"primaryCompletion":726,"completion":727,"start":728,"enrollment":729,"conditions":730,"interventions":732},"NCT01831453","Omega-3 and Quality of Life in Recurrent Aphthous Stomatitis Patients",[68],"2013-04","2013-05","2012-04",50,[731],"Recurrent Mouth Ulcers",[714],{"trials":734,"activeCount":78},[],{"trials":736,"activeCount":78},[],{"trials":738,"activeCount":78},[],{"intervention":630,"totalTrials":74,"cells":740},{"EARLY_PHASE1":741,"PHASE1":743,"PHASE2":745,"PHASE3":751,"PHASE4":753,"NA":755},{"trials":742,"activeCount":78},[],{"trials":744,"activeCount":78},[],{"trials":746,"activeCount":78},[747],{"nctId":621,"briefTitle":622,"status":296,"phases":748,"primaryCompletion":624,"completion":625,"start":626,"enrollment":90,"conditions":749,"interventions":750},[68],[628],[630,612],{"trials":752,"activeCount":78},[],{"trials":754,"activeCount":78},[],{"trials":756,"activeCount":78},[],{"intervention":758,"totalTrials":74,"cells":759},"Rebamipide",{"EARLY_PHASE1":760,"PHASE1":762,"PHASE2":764,"PHASE3":775,"PHASE4":777,"NA":779},{"trials":761,"activeCount":78},[],{"trials":763,"activeCount":78},[],{"trials":765,"activeCount":78},[766],{"nctId":767,"briefTitle":768,"status":296,"phases":769,"primaryCompletion":770,"completion":771,"start":772,"enrollment":90,"conditions":773,"interventions":774},"NCT05166304","Rebamipide in Patients With Active Rheumatoid Arthritis",[67,68],"2025-08-01","2025-09-01","2024-01-01",[28],[758],{"trials":776,"activeCount":78},[],{"trials":778,"activeCount":78},[],{"trials":780,"activeCount":78},[],{"intervention":641,"totalTrials":74,"cells":782},{"EARLY_PHASE1":783,"PHASE1":785,"PHASE2":787,"PHASE3":793,"PHASE4":795,"NA":797},{"trials":784,"activeCount":78},[],{"trials":786,"activeCount":78},[],{"trials":788,"activeCount":78},[789],{"nctId":632,"briefTitle":633,"status":342,"phases":790,"primaryCompletion":635,"completion":48,"start":636,"enrollment":90,"conditions":791,"interventions":792},[68],[638,639],[641,642],{"trials":794,"activeCount":78},[],{"trials":796,"activeCount":78},[],{"trials":798,"activeCount":78},[],{"intervention":800,"totalTrials":74,"cells":801},"Prednisone tablet 5mg",{"EARLY_PHASE1":802,"PHASE1":804,"PHASE2":806,"PHASE3":817,"PHASE4":819,"NA":821},{"trials":803,"activeCount":78},[],{"trials":805,"activeCount":78},[],{"trials":807,"activeCount":78},[808],{"nctId":809,"briefTitle":810,"status":296,"phases":811,"primaryCompletion":812,"completion":813,"start":727,"enrollment":276,"conditions":814,"interventions":815},"NCT02106468","The Efficacy of Omega-3 in Treatment of Atrophic\u002FErosive Lichen Planus",[68],"2014-06","2015-02",[586],[800,816],"Omega-3 soft capsules 1000 mg",{"trials":818,"activeCount":78},[],{"trials":820,"activeCount":78},[],{"trials":822,"activeCount":78},[],{"intervention":816,"totalTrials":74,"cells":824},{"EARLY_PHASE1":825,"PHASE1":827,"PHASE2":829,"PHASE3":835,"PHASE4":837,"NA":839},{"trials":826,"activeCount":78},[],{"trials":828,"activeCount":78},[],{"trials":830,"activeCount":78},[831],{"nctId":809,"briefTitle":810,"status":296,"phases":832,"primaryCompletion":812,"completion":813,"start":727,"enrollment":276,"conditions":833,"interventions":834},[68],[586],[800,816],{"trials":836,"activeCount":78},[],{"trials":838,"activeCount":78},[],{"trials":840,"activeCount":78},[],{"intervention":842,"totalTrials":74,"cells":843},"Ozonated olive oil gel",{"EARLY_PHASE1":844,"PHASE1":846,"PHASE2":848,"PHASE3":860,"PHASE4":862,"NA":864},{"trials":845,"activeCount":78},[],{"trials":847,"activeCount":78},[],{"trials":849,"activeCount":78},[850],{"nctId":851,"briefTitle":852,"status":296,"phases":853,"primaryCompletion":854,"completion":855,"start":856,"enrollment":301,"conditions":857,"interventions":859},"NCT02066337","Effect of Ozone Gel on Treatment of Chronic Periodontitis",[68],"2014-01","2014-02","2013-03",[858],"Periodontal Diseases",[842],{"trials":861,"activeCount":78},[],{"trials":863,"activeCount":78},[],{"trials":865,"activeCount":78},[],{"intervention":867,"totalTrials":74,"cells":868},"Dexmedetomidine",{"EARLY_PHASE1":869,"PHASE1":871,"PHASE2":873,"PHASE3":887,"PHASE4":889,"NA":891},{"trials":870,"activeCount":78},[],{"trials":872,"activeCount":78},[],{"trials":874,"activeCount":78},[875],{"nctId":876,"briefTitle":877,"status":296,"phases":878,"primaryCompletion":879,"completion":880,"start":881,"enrollment":149,"conditions":882,"interventions":884},"NCT05590234","Dexmedetomidine Combined With Bupivacaine for Erector Spinae Plane Block",[67,68],"2023-07-01","2023-07-20","2022-11-15",[883],"Posterior Lumbosacral Spine Fixation Surgeries",[867,885,886],"Bupivacaine 0.25% Injectable Solution","normal saline",{"trials":888,"activeCount":78},[],{"trials":890,"activeCount":78},[],{"trials":892,"activeCount":78},[],{"intervention":885,"totalTrials":74,"cells":894},{"EARLY_PHASE1":895,"PHASE1":897,"PHASE2":899,"PHASE3":905,"PHASE4":907,"NA":909},{"trials":896,"activeCount":78},[],{"trials":898,"activeCount":78},[],{"trials":900,"activeCount":78},[901],{"nctId":876,"briefTitle":877,"status":296,"phases":902,"primaryCompletion":879,"completion":880,"start":881,"enrollment":149,"conditions":903,"interventions":904},[67,68],[883],[867,885,886],{"trials":906,"activeCount":78},[],{"trials":908,"activeCount":78},[],{"trials":910,"activeCount":78},[],{"intervention":886,"totalTrials":74,"cells":912},{"EARLY_PHASE1":913,"PHASE1":915,"PHASE2":917,"PHASE3":923,"PHASE4":925,"NA":927},{"trials":914,"activeCount":78},[],{"trials":916,"activeCount":78},[],{"trials":918,"activeCount":78},[919],{"nctId":876,"briefTitle":877,"status":296,"phases":920,"primaryCompletion":879,"completion":880,"start":881,"enrollment":149,"conditions":921,"interventions":922},[67,68],[883],[867,885,886],{"trials":924,"activeCount":78},[],{"trials":926,"activeCount":78},[],{"trials":928,"activeCount":78},[],{"intervention":930,"totalTrials":74,"cells":931},"Sugar pill",{"EARLY_PHASE1":932,"PHASE1":934,"PHASE2":936,"PHASE3":948,"PHASE4":950,"NA":952},{"trials":933,"activeCount":78},[],{"trials":935,"activeCount":78},[],{"trials":937,"activeCount":78},[938],{"nctId":939,"briefTitle":940,"status":296,"phases":941,"primaryCompletion":942,"completion":943,"start":944,"enrollment":301,"conditions":945,"interventions":947},"NCT01113528","Omega-3 and Aspirin in Periodontal Regeneration",[68],"2009-12","2010-05","2009-11",[946],"Periodontal Disease",[930],{"trials":949,"activeCount":78},[],{"trials":951,"activeCount":78},[],{"trials":953,"activeCount":78},[],{"intervention":955,"totalTrials":74,"cells":956},"ORAL ANTIBIOTIC",{"EARLY_PHASE1":957,"PHASE1":968,"PHASE2":970,"PHASE3":972,"PHASE4":974,"NA":976},{"trials":958,"activeCount":78},[959],{"nctId":960,"briefTitle":961,"status":342,"phases":962,"primaryCompletion":963,"completion":963,"start":964,"enrollment":301,"conditions":965,"interventions":967},"NCT05675293","Cervicitis by Iontophoresis",[66],"2023-02","2023-01-15",[966],"CERVICITIS",[955],{"trials":969,"activeCount":78},[],{"trials":971,"activeCount":78},[],{"trials":973,"activeCount":78},[],{"trials":975,"activeCount":78},[],{"trials":977,"activeCount":78},[],{"intervention":979,"totalTrials":74,"cells":980},"SGLT2 inhibitors",{"EARLY_PHASE1":981,"PHASE1":983,"PHASE2":985,"PHASE3":987,"PHASE4":989,"NA":991},{"trials":982,"activeCount":78},[],{"trials":984,"activeCount":78},[],{"trials":986,"activeCount":78},[],{"trials":988,"activeCount":78},[],{"trials":990,"activeCount":78},[],{"trials":992,"activeCount":78},[993],{"nctId":994,"briefTitle":995,"status":342,"phases":996,"primaryCompletion":275,"completion":538,"start":997,"enrollment":998,"conditions":999,"interventions":1002},"NCT06201000","Effect of Genetic Polymorphisms on the Clinical Response to SGLT2 Inhibitors in Heart Failure Patients",[],"2023-12-27",282,[1000,1001],"Genetic Polymorphisms","Heart Failure",[979],{"intervention":1004,"totalTrials":74,"cells":1005},"Fibromyalgia Agents",{"EARLY_PHASE1":1006,"PHASE1":1008,"PHASE2":1010,"PHASE3":1012,"PHASE4":1014,"NA":1016},{"trials":1007,"activeCount":78},[],{"trials":1009,"activeCount":78},[],{"trials":1011,"activeCount":78},[],{"trials":1013,"activeCount":78},[],{"trials":1015,"activeCount":78},[],{"trials":1017,"activeCount":78},[1018],{"nctId":1019,"briefTitle":1020,"status":296,"phases":1021,"primaryCompletion":1022,"completion":1022,"start":1023,"enrollment":90,"conditions":1024,"interventions":1025},"NCT05550883","Aerobic Exercise for Women With Fibromyalgia",[71],"2022-09-01","2022-01-15",[33],[1004],{"intervention":1027,"totalTrials":74,"cells":1028},"MEBO",{"EARLY_PHASE1":1029,"PHASE1":1031,"PHASE2":1033,"PHASE3":1035,"PHASE4":1037,"NA":1039},{"trials":1030,"activeCount":78},[],{"trials":1032,"activeCount":78},[],{"trials":1034,"activeCount":78},[],{"trials":1036,"activeCount":78},[],{"trials":1038,"activeCount":78},[],{"trials":1040,"activeCount":78},[1041],{"nctId":1042,"briefTitle":1043,"status":296,"phases":1044,"primaryCompletion":1045,"completion":1045,"start":879,"enrollment":1046,"conditions":1047,"interventions":1052},"NCT06184282","Topical Mebo Versus Lidocane in Healing Time of Traumatic Oral Ulcer",[71],"2023-08-01",28,[1048,1049,1050,1051],"Mebo","Lidocaine","Healing","Traumatic Oral Ulceration",[1027,1049],{"intervention":1049,"totalTrials":74,"cells":1054},{"EARLY_PHASE1":1055,"PHASE1":1057,"PHASE2":1059,"PHASE3":1061,"PHASE4":1063,"NA":1065},{"trials":1056,"activeCount":78},[],{"trials":1058,"activeCount":78},[],{"trials":1060,"activeCount":78},[],{"trials":1062,"activeCount":78},[],{"trials":1064,"activeCount":78},[],{"trials":1066,"activeCount":78},[1067],{"nctId":1042,"briefTitle":1043,"status":296,"phases":1068,"primaryCompletion":1045,"completion":1045,"start":879,"enrollment":1046,"conditions":1069,"interventions":1070},[71],[1048,1049,1050,1051],[1027,1049],{"intervention":1072,"totalTrials":74,"cells":1073},"Saline",{"EARLY_PHASE1":1074,"PHASE1":1076,"PHASE2":1078,"PHASE3":1080,"PHASE4":1082,"NA":1084},{"trials":1075,"activeCount":78},[],{"trials":1077,"activeCount":78},[],{"trials":1079,"activeCount":78},[],{"trials":1081,"activeCount":78},[],{"trials":1083,"activeCount":78},[],{"trials":1085,"activeCount":78},[1086],{"nctId":1087,"briefTitle":1088,"status":296,"phases":1089,"primaryCompletion":1090,"completion":1091,"start":1092,"enrollment":1093,"conditions":1094,"interventions":1097},"NCT06304259","Effect of Different Modalities of Cryotherapy on Post-Operative Pain in Patients With Symptomatic Irreversible Pulpitis",[71],"2025-04-01","2025-07-01","2024-04-01",45,[1095,1096],"Endodontic Disease","Endodontically Treated Teeth",[1072,1072],{"intervention":1099,"totalTrials":74,"cells":1100},"Crespine gel",{"EARLY_PHASE1":1101,"PHASE1":1103,"PHASE2":1105,"PHASE3":1107,"PHASE4":1109,"NA":1111},{"trials":1102,"activeCount":78},[],{"trials":1104,"activeCount":78},[],{"trials":1106,"activeCount":78},[],{"trials":1108,"activeCount":78},[],{"trials":1110,"activeCount":78},[],{"trials":1112,"activeCount":78},[1113],{"nctId":1114,"briefTitle":1115,"status":342,"phases":1116,"primaryCompletion":1117,"completion":1118,"start":1119,"enrollment":1120,"conditions":1121,"interventions":1123},"NCT01998308","Comparison Between Four Types of Single Dose Hyaluronic Acid Injection in Patients With Knee Osteoarthritis",[],"2017-12","2019-12","2012-12",200,[1122],"Osteoarthritis",[1099,1124,1125,1126],"Intragel","Crespine plus gel","Monovisc",{"intervention":1124,"totalTrials":74,"cells":1128},{"EARLY_PHASE1":1129,"PHASE1":1131,"PHASE2":1133,"PHASE3":1135,"PHASE4":1137,"NA":1139},{"trials":1130,"activeCount":78},[],{"trials":1132,"activeCount":78},[],{"trials":1134,"activeCount":78},[],{"trials":1136,"activeCount":78},[],{"trials":1138,"activeCount":78},[],{"trials":1140,"activeCount":78},[1141],{"nctId":1114,"briefTitle":1115,"status":342,"phases":1142,"primaryCompletion":1117,"completion":1118,"start":1119,"enrollment":1120,"conditions":1143,"interventions":1144},[],[1122],[1099,1124,1125,1126],{"intervention":1125,"totalTrials":74,"cells":1146},{"EARLY_PHASE1":1147,"PHASE1":1149,"PHASE2":1151,"PHASE3":1153,"PHASE4":1155,"NA":1157},{"trials":1148,"activeCount":78},[],{"trials":1150,"activeCount":78},[],{"trials":1152,"activeCount":78},[],{"trials":1154,"activeCount":78},[],{"trials":1156,"activeCount":78},[],{"trials":1158,"activeCount":78},[1159],{"nctId":1114,"briefTitle":1115,"status":342,"phases":1160,"primaryCompletion":1117,"completion":1118,"start":1119,"enrollment":1120,"conditions":1161,"interventions":1162},[],[1122],[1099,1124,1125,1126],{"intervention":1126,"totalTrials":74,"cells":1164},{"EARLY_PHASE1":1165,"PHASE1":1167,"PHASE2":1169,"PHASE3":1171,"PHASE4":1173,"NA":1175},{"trials":1166,"activeCount":78},[],{"trials":1168,"activeCount":78},[],{"trials":1170,"activeCount":78},[],{"trials":1172,"activeCount":78},[],{"trials":1174,"activeCount":78},[],{"trials":1176,"activeCount":78},[1177],{"nctId":1114,"briefTitle":1115,"status":342,"phases":1178,"primaryCompletion":1117,"completion":1118,"start":1119,"enrollment":1120,"conditions":1179,"interventions":1180},[],[1122],[1099,1124,1125,1126],{"intervention":1182,"totalTrials":74,"cells":1183},"Continuous infusion Linezolid",{"EARLY_PHASE1":1184,"PHASE1":1186,"PHASE2":1188,"PHASE3":1190,"PHASE4":1192,"NA":1194},{"trials":1185,"activeCount":78},[],{"trials":1187,"activeCount":78},[],{"trials":1189,"activeCount":78},[],{"trials":1191,"activeCount":78},[],{"trials":1193,"activeCount":78},[],{"trials":1195,"activeCount":78},[1196],{"nctId":1197,"briefTitle":1198,"status":342,"phases":1199,"primaryCompletion":1200,"completion":1200,"start":1201,"enrollment":1202,"conditions":1203,"interventions":1204},"NCT04531332","Continuous Infusion of Linezolid Versus Intermittent Dosing in the Treatment of Nosocomial Pneumonia",[71],"2021-09-15","2019-11-15",169,[349],[1182,1205],"intermittent dosing linezolid",{"intervention":1205,"totalTrials":74,"cells":1207},{"EARLY_PHASE1":1208,"PHASE1":1210,"PHASE2":1212,"PHASE3":1214,"PHASE4":1216,"NA":1218},{"trials":1209,"activeCount":78},[],{"trials":1211,"activeCount":78},[],{"trials":1213,"activeCount":78},[],{"trials":1215,"activeCount":78},[],{"trials":1217,"activeCount":78},[],{"trials":1219,"activeCount":78},[1220],{"nctId":1197,"briefTitle":1198,"status":342,"phases":1221,"primaryCompletion":1200,"completion":1200,"start":1201,"enrollment":1202,"conditions":1222,"interventions":1223},[71],[349],[1182,1205],{"intervention":1225,"totalTrials":74,"cells":1226},"Xenical",{"EARLY_PHASE1":1227,"PHASE1":1229,"PHASE2":1231,"PHASE3":1233,"PHASE4":1235,"NA":1237},{"trials":1228,"activeCount":78},[],{"trials":1230,"activeCount":78},[],{"trials":1232,"activeCount":78},[],{"trials":1234,"activeCount":78},[],{"trials":1236,"activeCount":78},[],{"trials":1238,"activeCount":78},[1239],{"nctId":1240,"briefTitle":1241,"status":296,"phases":1242,"primaryCompletion":1243,"completion":1243,"start":1244,"enrollment":1245,"conditions":1246,"interventions":1249},"NCT06625736","Anti-obesity Effects of Dandelion (Taraxacum Officinale L.)",[71],"2024-09-07","2024-01-05",120,[1247,1248],"Obese Women","Perimenopause",[1225],{"intervention":1251,"totalTrials":74,"cells":1252},"Group A (n = 20): received core stability exercise trained three times a week for 8 weeks.",{"EARLY_PHASE1":1253,"PHASE1":1255,"PHASE2":1257,"PHASE3":1259,"PHASE4":1261,"NA":1263},{"trials":1254,"activeCount":78},[],{"trials":1256,"activeCount":78},[],{"trials":1258,"activeCount":78},[],{"trials":1260,"activeCount":78},[],{"trials":1262,"activeCount":78},[],{"trials":1264,"activeCount":78},[1265],{"nctId":1266,"briefTitle":1267,"status":296,"phases":1268,"primaryCompletion":1269,"completion":1270,"start":1271,"enrollment":301,"conditions":1272,"interventions":1274},"NCT06721637","Effect of Core Stability Exercise Versus Whole Body Vibration in Improving Vitamin D Absorption in Women",[],"2024-07-15","2024-11-25","2024-06-09",[1273],"Vitamin D Absorption",[1251]]